Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 2
116
Views
11
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Presence and ex vivo formation of acridone in blood of patients routinely treated with carbamazepine: exploration of the 9-acridinecarboxaldehyde pathway

, &
Pages 91-100 | Received 08 Jul 2010, Accepted 04 Oct 2010, Published online: 18 Nov 2010

References

  • Allen RC. (1994). Role of oxygen in phagocyte microbicidal action. Environ Health Perspect 102 Suppl 10:201–208.
  • Beyer C, Spiteller G. (1992). A new carbamazepine metabolite in uraemic filtrate. Xenobiotica 22:1029–1035.
  • Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. (2005). Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 828:80–90.
  • Chiron S, Minero C, Vione D. (2006). Photodegradation processes of the antiepileptic drug carbamazepine, relevant to estuarine waters. Environ Sci Technol 40:5977–5983.
  • de Voogt P, Bleeker EA, van Vlaardingen PL, Fernández A, Slobodník J, Wever H, Kraak MH. (1999). Formation and identification of azaarene transformation products from aquatic invertebrate and algal metabolism. J Chromatogr B Biomed Sci Appl 724:265–274.
  • Eichelbaum M, Tomson T, Tybring G, Bertilsson L. (1985). Carbamazepine metabolism in man. Induction and pharmacogenetic aspects. Clin Pharmacokinet 10:80–90.
  • Friedmann PS, Strickland I, Pirmohamed M, Park BK. (1994). Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 130:598–604.
  • Furst SM, Uetrecht JP. (1993). Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils. Biochem Pharmacol 45:1267–1275.
  • Furst SM, Uetrecht JP. (1995). The effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro. Int J Immunopharmacol 17:445–452.
  • Furst SM, Sukhai P, McClelland RA, Uetrecht JP. (1995). Covalent binding of carbamazepine oxidative metabolites to neutrophils. Drug Metab Dispos 23:590–594.
  • Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, Hristakieva E, Tzaneva V. (2008). Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 47:853–860.
  • Ju C, Uetrecht JP. (1999). Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288:51–56.
  • Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, Levy RH. (1994). Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 47:1969–1979.
  • Kraak MHS, Ainscough C, Fernandez A, van Vlaardingen PLA, de Voogt P, Admiraal WA. (1997). Short-term and chronic exposure of the zebra mussel (Dreissena polymorpha) to acridine: effects and metabolism. Aquatic Toxicology, 37, 9–20.
  • Leclercq M, Mathieu O, Gomez E, Casellas C, Fenet H, Hillaire-Buys D. (2009). Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch Environ Contam Toxicol 56:408–415.
  • Mandrioli R, Albani F, Casamenti G, Sabbioni C, Raggia MA. (2001). Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients. J Chromatogr B Biomed Sci Appl 762:109–116.
  • Marmurowska-Michalowska H, Szuster-Ciesielska A, Kandefer-Szerszen M, Dubas-Slemp H. (2004). The influence of carbamazepine on cytokine and superoxide anion production in blood leukocytes of healthy volunteers. Ann Univ Mariae Curie Sklodowska Med 59:201–206.
  • McMurtrey KD, Knight TJ. (1984). Metabolism of acridine by rat-liver enzymes. Mutat Res 140:7–11.
  • Myllynen P, Pienimäki P, Raunio H, Vähäkangas K. (1998). Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta. Hum Exp Toxicol 17:668–676.
  • Pearce RE, Vakkalagadda GR, Leeder JS. (2002). Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites. Drug Metab Dispos 30:1170–1179.
  • Pearce RE, Uetrecht JP, Leeder JS. (2005). Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene. Drug Metab Dispos 33:1819–1826.
  • Pearce RE, Lu W, Wang Y, Uetrecht JP, Correia MA, Leeder JS. (2008). Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine. Drug Metab Dispos 36:1637–1649.
  • Pienimäki P, Fuchs S, Isojärvi J, Vähäkangas K. (1995). Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography. J Chromatogr B, Biomed Appl 673:97–105.
  • Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK. (1992). An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol 43:1675–1682.
  • Robertson IG, Bland TJ. (1993). Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide. Biochem Pharmacol 45:2159–2162.
  • Siddiqui RA, English D, Harvey K, Cui Y, Martin MI, Wentland J, Akard L, Jansen J, Thompson J, Garcia JG. (1995). Phorbol ester-induced priming of superoxide generation by phosphatidic acid-stimulated neutrophils and granule-free neutrophil cytoplasts. J Leukoc Biol 58:189–195.
  • Silverman DA, Chapron DJ. (1995). Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemia. Ann Pharmacother 29:865–867.
  • Vogna D, Marotta R, Andreozzi R, Napolitano A, d’Ischia M. (2004). Kinetic and chemical assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine. Chemosphere 54:497–505.
  • Wad N, Guenat C, Krämer G. (1997). Carbamazepine: detection of another metabolite in serum, 9 hydroxymethyl-10-carbamoyl acridan. Ther Drug Monit 19:314–317.
  • Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, Pirmohamed M, Park BK, Naisbitt DJ. (2006). Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 118:233–241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.